(Q41451925)

30 September 2017

1 reference

title

The integrated effects of angiotensin II. (English)

1 reference

30 September 2017

R J Cody

1

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

American Journal of Cardiology

30 September 2017

published in

1 reference

30 September 2017

volume

79

1 reference

30 September 2017

issue

5A

1 reference

30 September 2017

page(s)

9-11

1 reference

The clinical potential of renin inhibitors and angiotensin antagonists

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Renin system inhibition. Beginning the fourth epoch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Prospects for cardioreparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Structural remodeling in hypertensive heart disease and the role of hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Angiotensin AT1 receptors mediate a positive inotropic effect of angiotensin II in guinea pig atria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900123-9

10.1016/S0002-9149(97)00123-9

7 January 2021

Identifiers

DOI

1 reference

30 September 2017

1 reference